ArticleACS infectious diseases2018
New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii.
Bradley M Minrovic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it